Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.

Theodoros Kalampokas, George Creatsas, Emmanouil Kalampokas

Second Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, Athens, Greece. kalamp@yahoo.com

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2013 Feb

filter terms:

One of the most serious complications of assisted reproduction techniques is ovarian hyperstimulation syndrome (OHSS). OHSS not only increases morbidity and mortality in IFV cycles, but also causes significant other problems, as cancelled in vitro fertilization (IVF) cycles, prolonged hospitalization, causing emotional and sociofinancial consequences. Several treatments for OHSS have been proposed and among these Cabergoline (Cb2). Despite the above-mentioned beneficial effect, Cb2 has not been widely used in everyday's clinical practice. With our study, we try to review all studies with strong evidence examining Cb2 use for OHSS prevention.

Citation

Theodoros Kalampokas, George Creatsas, Emmanouil Kalampokas. Cabergoline as treatment of ovarian hyperstimulation syndrome: a review. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2013 Feb;29(2):98-100